Delivery Order SPE2DB20D3103-SPE2DB21FQ3C8
Award Date 9/16/21
Potential Completion Date 9/17/21
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.99 fixed-price delivery order contract is for the supply of Medroxyprogesterone, a pharmaceutical drug. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 150 mg/ml medroxyprogesterone injections. The contract has a ceiling value of $2,497.81 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 and running through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a firm fixed price, with a ceiling value of $3,016.81, and a performance period through July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, SPE2DX15D3018|SPE2DX23F0AWY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,886.33 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/ml, a medication used in various medical treatments. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,332.20 firm fixed-price contract is for the delivery of 4,568,260,604 milliliters of the drug medroxyprogesterone 150 mg/mL. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJFA3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,755.08 firm fixed-price delivery order is for the supply of 4566565091 - MEDROXYPROGESTERONE 150 MG/MLML, with a completion date of November 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560784607 units of Medroxyprogesterone 150 mg/ml, a pharmaceutical product, with a total ceiling value of $1,864.81 and a completion date of May 2, 2023. The contract is a delivery order with a firm fixed price and was awarded on May 1, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of medroxyprogesterone 150 mg/ml to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $1,319.02. This DO is likely part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,131.24 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. This contract is for the supply of 4564327234 Medroxyprogesterone 150 mg/ml, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ3C8Delivery Order
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,459.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 2/27/25, 12:39 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 9/16/21 |